文献速递脊柱脊髓外科神经肿瘤

黏液乳头型室管膜瘤的手术结局与复发危险因素:单中心经验

Surgical outcomes and risk factors for recurrence of myxopapillary ependymoma: a single-center experience.
PubMed 文献 · J Neurosurg Spine · 2023-06-30

该单中心研究回顾了28例病理确诊的脊髓黏液乳头型室管膜瘤,中位随访107个月。19例(68%)实现全切除,9例(32%)次全切除;次全切除组7例(77.8%)因复发再手术,全切除组无再手术。肿瘤大小和骶管受累影响可切除性。

要点

  • 28例脊髓黏液乳头型室管膜瘤中,全切除19例(68%),次全切除9例(32%)。
  • 次全切除组7例(77.8%)因复发再手术,中位再手术时间32个月;全切除组无再手术。
  • 术前无力和骶管受累在次全切除组更常见,次全切除组肿瘤更大、跨越更多脊髓节段。

核心结论

  • 肿瘤大小和位置(尤其是骶管受累)对决定可切除性很重要;次全切除者78%因复发需再手术,全切除者无需再手术,多数患者术后神经功能稳定。

研究设计与样本

  • 单中心回顾性病历复习,纳入28例病理确诊的脊髓黏液乳头型室管膜瘤患者,比较全切除组(19例)与次全切除组(9例)。

主要发现

  • 中位年龄43岁,中位术后随访107个月(范围5-372个月);所有患者均以疼痛起病,无力占25.0%、括约肌障碍占21.4%、麻木占14.3%。
  • 全切除19例(68%),次全切除9例(32%);术前无力和骶管受累在次全切除组更常见,次全切除组肿瘤更大且跨越更多脊髓节段。
  • 次全切除组术后改良McCormick量表分级显著高于全切除组(p=0.00175)。
  • 次全切除组9例中7例(77.8%)因复发再手术,中位再手术时间距初次手术32个月;全切除组无再手术,总体再手术率25%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Myxopapillary ependymomas (MPEs) are low-grade, well-circumscribed tumors that often involve the conus medullaris, cauda equina, or filum terminale. They account for up to 5% of all tumors of the spine and 13% of spinal ependymomas, with a peak incidence between 30 and 50 years of age. Because of the rarity of MPEs, their clinical course and optimal management strategy are not well defined, and long-term outcomes remain difficult to predict. The objective of this study was to review long-term clinical outcomes of spinal MPEs and identify factors that may predict tumor resectability and recurrence. METHODS: Pathologically confirmed cases of MPE at the authors' institution were identified and medical records were reviewed. Demographics, clinical presentation, imaging characteristics, surgical technique, follow-up, and outcome data were noted. Two groups of patients-those who underwent gross-total resection (GTR) and those who underwent subtotal resection (STR)-were compared using the Mann-Whitney U-test for continuous and ordinal variables and the Fisher exact test for categorical variables. Differences were considered statistically significant at p ≤ 0.05. RESULTS: Twenty-eight patients were identified, with a median age of 43 years at the index surgery. The median postoperative follow-up duration was 107 months (range 5-372 months). All patients presented with pain. Other common presenting symptoms were weakness (25.0%), sphincter disturbance (21.4%), and numbness (14.3%). GTR was achieved in 19 patients (68%) and STR in 9 (32%). Preoperative weakness and involvement of the sacral spinal canal were more common in the STR group. Tumors were larger and spanned more spinal levels in the STR group compared with the GTR cohort. Postoperative modified McCormick Scale grades were significantly higher in the STR cohort compared with the GTR group (p = 0.00175). Seven of the 9 STR patients (77.8%) underwent reoperation for recurrence at a median of 32 months from the index operation, while no patients required reoperation after GTR, for an overall reoperation rate of 25%. CONCLUSIONS: Findings of this study emphasize the importance of tumor size and location-particularly involvement of the sacral canal-in determining resectability. Reoperation for recurrence was necessary in 78% of patients with subtotally resected tumors; none of the patients who underwent GTR required reoperation. Most patients had stable neurological status postoperatively.

来源:J Neurosurg Spine,查看原文。版权归原作者所有。

引用

  1. Dougherty MC, Sandhu MRS, Teferi N, et al. Surgical outcomes and risk factors for recurrence of myxopapillary ependymoma: a single-center experience. J Neurosurg Spine. 2023. PMID: 37410596. doi:10.3171/2023.5.SPINE23433

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。